Suboxone is the brand name of combination of Buprenorphine and Naloxone, manufactured by Indivior, Inc., and used in the treatment of opioid dependence. In January of 2022, the FDA issued a drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback